9 results match your criteria: "Copenhagen University Hospital Rigshopitalet[Affiliation]"
Int J Neonatal Screen
October 2024
Department of Gynecology, Copenhagen University Hospital Rigshopitalet, 2100 Copenhagen, Denmark.
X-linked adrenoleukodystrophy (ALD) is a rare metabolic disorder. Symptoms range from cerebral demyelination (cALD) to adrenal insufficiency and slowly progressive myeloneuropathy. cALD is fatal if not treated with hematopoietic cell transplantation in the early stages of the disease course.
View Article and Find Full Text PDFJ Clin Epidemiol
June 2023
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Objectives: To systematically survey Cochrane reviews' approaches to calculating, presenting, and interpreting pooled estimates of patient-reported outcome measures (PROMs).
Study Design And Setting: We retrospectively selected 200 Cochrane reviews that met the eligibility criteria. Two researchers independently extracted the pooled effect measures and approaches for pooling and interpreting the effect measures, reaching consensus through discussions.
Int J Epidemiol
June 2022
Center of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
BMC Nephrol
September 2020
Department of Cardiology, Copenhagen University Hospital Herlev, Borgmester Ib Juuls Vej 1, 2730, Herlev, Denmark.
Background: Cardiovascular disease is the most common cause of death in patients with end-stage kidney disease on haemodialysis. The potential clinical consequence of systematic echocardiographic assessment is however not clear. In an unselected, contemporary population of patients on maintenance haemodialysis we aimed to assess: the prevalence of structural and functional heart disease, the potential therapeutic consequences of echocardiographic screening and whether left-sided heart disease is associated with prognosis.
View Article and Find Full Text PDFCancer Immunol Immunother
February 2018
Therapeutic Immunology, F79, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Hälsovägen, Huddinge, 14186, Stockholm, Sweden.
The prognosis for patients with glioblastoma is grim. Ex vivo expanded tumor-associated antigen (TAA)-reactive T-cells from patients with glioma may represent a viable source for anticancer-directed cellular therapies. Immunohistochemistry was used to test the survivin (n = 40 samples) and NY-ESO-1 (n = 38 samples) protein expression in tumor specimens.
View Article and Find Full Text PDFInt J Gynecol Cancer
March 2017
From the Department of Gynecology and Obstetrics, Copenhagen University Hospital - RIGSHOPITALET, København Ø, Denmark.
Objective: The aim of this study was to assess the importance of appendectomy during surgery for mucinous ovarian cancer. It can be difficult to distinguish between primary ovarian and primary appendiceal cancers clinically, histologically, and immunohistochemically. Removal of the appendix may facilitate differential diagnosis, improve staging, and possibly increase 5-year survival but may also be associated with increased postsurgical morbidity.
View Article and Find Full Text PDFScand J Immunol
May 2000
Departments of Infectious Diseases, Copenhagen University Hospital (Rigshopitalet), M7641, Tagensvej 20, 2200 Copenhagen N, Denmark.
To determine the efficacy of combined G-CSF and highly active antiretroviral treatment (HAART), a randomized, double blind, placebo controlled study was conducted. Treatment naive human immunodeficiency virus (HIV) infected patients were randomized to receive either placebo or G-CSF (0.3 mg/ml, 3 times a week) for 12 weeks and HAART simultaneously.
View Article and Find Full Text PDFPediatr Pulmonol
September 1999
Department of Pediatrics, Copenhagen Cystic Fibrosis Centre, Copenhagen University Hospital (Rigshopitalet), Denmark.
Recurrent and chronic lower airway infection with Pseudomonas aeruginosa (PA) is an important component of cystic fibrosis (CF) pulmonary disease. Different modes of treatment and control of CF patients have been introduced at the Copenhagen CF Centre over the past 20 years and have been associated with improved survival. Treatment consisted of: 1) elective antibiotics for 14 days every 3 months to patients with chronic PA infection (started in 1976), 2) cohort isolation to prevent cross-infection (patients with PA were separated from patients without PA, starting in 1981); and 3) early intensive treatment with inhaled colistin and oral ciprofloxacin from time of initial PA colonization (started in 1989).
View Article and Find Full Text PDFInfect Immun
April 1998
Department of Infectious Diseases, Centre for Medical Parasitology, Copenhagen University Hospital (Rigshopitalet), Denmark.
Healthy Gambian children, children with clinical Plasmodium falciparum malaria, and children with asymptomatic P. falciparum infections were studied to investigate whether antitoxic activities may contribute to protection against malarial symptoms. Markers of inflammatory reactions, soluble tumor necrosis factor receptor I, and C-reactive protein were found in high concentrations in children with symptomatic P.
View Article and Find Full Text PDF